Global Krabbe disease treatment market 2024-2028

PUBLISHED: June 13, 2024

PAGES: 145 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The krabbe disease treatment market is forecasted to grow by USD 405.4 mn during 2023-2028, accelerating at a CAGR of 7.08% during the forecast period. The report on the krabbe disease treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by special drug designation, unmet clinical needs, and practice of consanguineous marriage.

Technavio's krabbe disease treatment market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.49%
CAGR	7.08%
Incremental Value	$405.4mn

By Therapy

Anticonvulsants
Muscle relaxants
HSCT
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of pharmacological chaperone therapy as one of the prime reasons driving the krabbe disease treatment market growth during the next few years. Also, gene technology in therapy and increasing degree of awareness about krabbe disease will lead to sizable demand in the market.

The report on the krabbe disease treatment market covers the following areas:

Krabbe disease treatment market sizing
Krabbe disease treatment market forecast
Krabbe disease treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading krabbe disease treatment market vendors that include AbbVie Inc., Acorda Therapeutics Inc., CENTOGENE NV, GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Novartis AG, Pfizer Inc., Polaryx, Teva Pharmaceutical Industries Ltd., and UCB SA. Also, the krabbe disease treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73314

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Krabbe Disease Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Krabbe Disease Treatment Market 2018 - 2022 ($ million)
4.2 Therapy segment analysis 2018 - 2022
- Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy

6.1 Market segments
- Chart on Therapy - Market share 2023-2028 (%)
- Data Table on Therapy - Market share 2023-2028 (%)
6.2 Comparison by Therapy
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy
6.3 Anticonvulsants - Market size and forecast 2023-2028
- Chart on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
- Data Table on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
- Chart on Anticonvulsants - Year-over-year growth 2023-2028 (%)
- Data Table on Anticonvulsants - Year-over-year growth 2023-2028 (%)
6.4 Muscle relaxants - Market size and forecast 2023-2028
- Chart on Muscle relaxants - Market size and forecast 2023-2028 ($ million)
- Data Table on Muscle relaxants - Market size and forecast 2023-2028 ($ million)
- Chart on Muscle relaxants - Year-over-year growth 2023-2028 (%)
- Data Table on Muscle relaxants - Year-over-year growth 2023-2028 (%)
6.5 HSCT - Market size and forecast 2023-2028
- Chart on HSCT - Market size and forecast 2023-2028 ($ million)
- Data Table on HSCT - Market size and forecast 2023-2028 ($ million)
- Chart on HSCT - Year-over-year growth 2023-2028 (%)
- Data Table on HSCT - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Therapy
- Market opportunity by Therapy ($ million)
- Data Table on Market opportunity by Therapy ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
11.4 Acorda Therapeutics Inc.
- Acorda Therapeutics Inc. - Overview
- Acorda Therapeutics Inc. - Product / Service
- Acorda Therapeutics Inc. - Key offerings
11.5 CENTOGENE NV
- CENTOGENE NV - Overview
- CENTOGENE NV - Product / Service
- CENTOGENE NV - Key offerings
11.6 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
11.7 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
11.8 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
11.9 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
11.10 Polaryx
- Polaryx - Overview
- Polaryx - Product / Service
- Polaryx - Key offerings
11.11 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
11.12 UCB SA
- UCB SA - Overview
- UCB SA - Product / Service
- UCB SA - Key offerings

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR73314

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Krabbe Disease Treatment Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Therapy - Market share 2023-2028 (%)
Exhibits31: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Anticonvulsants - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Anticonvulsants - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Muscle relaxants - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Muscle relaxants - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Muscle relaxants - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Muscle relaxants - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on HSCT - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on HSCT - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on HSCT - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on HSCT - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Therapy ($ million)
Exhibits51: Data Table on Market opportunity by Therapy ($ million)
Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits53: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits54: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits55: Chart on Geographic comparison
Exhibits56: Data Table on Geographic comparison
Exhibits57: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits93: Market opportunity By Geographical Landscape ($ million)
Exhibits94: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits95: Impact of drivers and challenges in 2023 and 2028
Exhibits96: Overview on criticality of inputs and factors of differentiation
Exhibits97: Overview on factors of disruption
Exhibits98: Impact of key risks on business
Exhibits99: Companies covered
Exhibits100: Matrix on companies position and classification
Exhibits101: AbbVie Inc. - Overview
Exhibits102: AbbVie Inc. - Product / Service
Exhibits103: AbbVie Inc. - Key news
Exhibits104: AbbVie Inc. - Key offerings
Exhibits105: Acorda Therapeutics Inc. - Overview
Exhibits106: Acorda Therapeutics Inc. - Product / Service
Exhibits107: Acorda Therapeutics Inc. - Key offerings
Exhibits108: CENTOGENE NV - Overview
Exhibits109: CENTOGENE NV - Product / Service
Exhibits110: CENTOGENE NV - Key offerings
Exhibits111: GlaxoSmithKline Plc - Overview
Exhibits112: GlaxoSmithKline Plc - Business segments
Exhibits113: GlaxoSmithKline Plc - Key news
Exhibits114: GlaxoSmithKline Plc - Key offerings
Exhibits115: GlaxoSmithKline Plc - Segment focus
Exhibits116: Johnson and Johnson Services Inc. - Overview
Exhibits117: Johnson and Johnson Services Inc. - Business segments
Exhibits118: Johnson and Johnson Services Inc. - Key news
Exhibits119: Johnson and Johnson Services Inc. - Key offerings
Exhibits120: Johnson and Johnson Services Inc. - Segment focus
Exhibits121: Novartis AG - Overview
Exhibits122: Novartis AG - Business segments
Exhibits123: Novartis AG - Key news
Exhibits124: Novartis AG - Key offerings
Exhibits125: Novartis AG - Segment focus
Exhibits126: Pfizer Inc. - Overview
Exhibits127: Pfizer Inc. - Product / Service
Exhibits128: Pfizer Inc. - Key news
Exhibits129: Pfizer Inc. - Key offerings
Exhibits130: Polaryx - Overview
Exhibits131: Polaryx - Product / Service
Exhibits132: Polaryx - Key offerings
Exhibits133: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits134: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits135: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits136: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits137: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits138: UCB SA - Overview
Exhibits139: UCB SA - Product / Service
Exhibits140: UCB SA - Key offerings
Exhibits141: Inclusions checklist
Exhibits142: Exclusions checklist
Exhibits143: Currency conversion rates for US$
Exhibits144: Research methodology
Exhibits145: Information sources
Exhibits146: Data validation
Exhibits147: Validation techniques employed for market sizing
Exhibits148: Data synthesis
Exhibits149: 360 degree market analysis
Exhibits150: List of abbreviations